Hope For Crohn’s Patients With Fistulas Found In HUMIRA/Adalimumab
Mar 14th 2008Drug InformationCrohn
At the recent European Crohn’s and Colitis Organization (ECCO) annualmeeting in Lyon, France, Abbott Laboratories announced that HUMIRA(Adalimumab) is successful in the treatment of fistulas in susceptibleCrohn’s patients. Crohn’sDisease (CD) is a gastrointestinal disorder which is indicated bychronicinflammation of the wall of the digestive tract.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.